Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma [Melanoma]

Conclusion
T-VEC with ipilimumab had a tolerable safety profile, and the combination appeared to have greater efficacy than either T-VEC or ipilimumab monotherapy.

Source: Journal of Clinical Oncology - July 19, 2016 Category: Cancer & Oncology Authors: Puzanov, Milhem, Minor, Hamid, Li, Chen, Chastain, Gorski, Anderson, Chou, Kaufman, Andtbacka Tags: Combined Modality Melanoma Source Type: research